Related Experiment Video

Updated: May 1, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

13.6K

Association between G6PD deficiency and hyperbilirubinemia in neonates: a meta-analysis

Huajun Liu1, Wenbin Liu, Xueqing Tang

  • 11Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan Province, China.

Pediatric Hematology and Oncology
|April 2, 2014
PubMed

Insights

Newborns with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency face a significantly higher risk of developing hyperbilirubinemia and requiring phototherapy. Early G6PD level monitoring is crucial for predicting and managing this condition in neonates.

Area of Science:

  • Neonatal Medicine
  • Pediatrics
  • Genetics

Background:

  • Neonatal hyperbilirubinemia is a common condition with various contributing factors.
  • Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is an identified risk factor, yet often overlooked in severe cases.
  • Pediatricians may not consistently consider G6PD deficiency's impact on neonatal jaundice.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the association between G6PD deficiency and the risk of hyperbilirubinemia in newborns.
  • To determine if G6PD deficiency increases the likelihood of neonates requiring phototherapy.
  • To provide evidence supporting the importance of G6PD screening in at-risk newborns.

Main Methods:

  • Systematic literature search of PubMed and Embase databases.
  • Inclusion and exclusion criteria applied to select relevant cohort studies.
  • Meta-analysis using Risk Ratios (RRs) and 95% Confidence Intervals (CIs).
  • Heterogeneity assessed using Cochrane Q and I² statistics.

Main Results:

  • Five cohort studies with 21,585 participants were included.
  • G6PD-deficient newborns showed a 3.92-fold increased risk of hyperbilirubinemia (95% CI, 2.13-7.20).
  • G6PD-deficient neonates had a 3.01-fold increased risk of receiving phototherapy (95% CI, 2.20-4.12).

Conclusions:

  • G6PD deficiency is significantly correlated with an increased risk of neonatal hyperbilirubinemia.
  • G6PD deficiency is associated with a higher likelihood of neonates needing phototherapy.
  • Monitoring G6PD levels in newborns is vital for predicting and managing hyperbilirubinemia.

Keywords:
G6PD deficiencymeta-analysisneonatal hyperbilirubinemiaphototherapy

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

5.5K
One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

16.2K

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
35
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
220
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.3K